Recent changes

Jump to: navigation, search

Track the most recent changes to the wiki on this page.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 19:18, 24 June 2019
   

24 June 2019

 m   17:52  Multiple myeloma, consolidation and maintenance‎ (diff | hist) . . (+66). . Jwarner (talk | contribs)
 m   17:52  Multiple myeloma - historical‎‎ (2 changes | history) . . (+1,068). . [Jwarner‎ (2×)]
 m    17:52 (cur | prev) . . (+1,053). . Jwarner (talk | contribs) (Observation)
 m    17:48 (cur | prev) . . (+15). . Jwarner (talk | contribs) (References)
 m   17:44  Gastric cancer‎ (diff | hist) . . (+945). . Jwarner (talk | contribs) (S-1 monotherapy {{#subobject:ec10ef|Regimen=1}})
     17:37  Paroxysmal nocturnal hemoglobinuria‎‎ (3 changes | history) . . (+3,939). . [Jwarner‎ (3×)]
 m    17:37 (cur | prev) . . (+5). . Jwarner (talk | contribs) (Ravulizumab monotherapy {{#subobject:abd213 |Regimen=1}})
 m    17:37 (cur | prev) . . (-28). . Jwarner (talk | contribs) (Investigational agents)
      17:37 (cur | prev) . . (+3,962). . Jwarner (talk | contribs) (All lines of therapy)
N    17:24  Category:FDA approved in 1944‎ (diff | hist) . . (+95). . Jwarner (talk | contribs) (Created page with "Drugs, devices, and/or biologics FDA approved in 1944. Category:FDA approved in the 1940's")
N    17:23  Penicillin V‎ (diff | hist) . . (+176). . Jwarner (talk | contribs) (Created page with "An antibiotic. Category:Drugs Category:Oral medications Category:Penicillin Category:FDA approved in 1944 Category:WHO Essential Anti-infective Medicines")
N    17:17  Ravulizumab (Ultomiris)‎ (diff | hist) . . (+1,940). . Jwarner (talk | contribs) (Created page with "==General information== Class/mechanism from the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/complement-c5-inhibitor-alxn1210 NCI Drug Dictionary]: A lon...")
 m   17:12  Drug index‎‎ (2 changes | history) . . (+85). . [Jwarner‎ (2×)]
 m    17:12 (cur | prev) . . (+59). . Jwarner (talk | contribs) (R)
 m    17:09 (cur | prev) . . (+26). . Jwarner (talk | contribs) (C)
 m   17:08  Folinic acid (Leucovorin)‎ (diff | hist) . . (+40). . Jwarner (talk | contribs) (Also known as)
 m   16:57  Small cell lung cancer - historical‎‎ (2 changes | history) . . (+217). . [Jwarner‎ (2×)]
 m    16:57 (cur | prev) . . (+115). . Jwarner (talk | contribs) (CAV {{#subobject:cbb2ff|Regimen=1}})
 m    12:52 (cur | prev) . . (+102). . Jwarner (talk | contribs) (ACE {{#subobject:9fbf31|Regimen=1}})
 m   16:52  Amsacrine (Amsidine)‎ (diff | hist) . . (+15). . Jwarner (talk | contribs) (Also known as)
 m   12:10  Soft tissue sarcoma‎ (diff | hist) . . (-46). . Jwarner (talk | contribs) (Doxorubicin & Ifosfamide {{#subobject:e28770|Regimen=1}})
 m   12:02  Acute myeloid leukemia‎ (diff | hist) . . (+76). . Jwarner (talk | contribs) (Upfront induction therapy, standard and older "fit" patients)

23 June 2019

 m   20:24  Esophageal cancer‎‎ (2 changes | history) . . (+120). . [Jwarner‎ (2×)]
 m    20:24 (cur | prev) . . (+53). . Jwarner (talk | contribs)
 m    19:40 (cur | prev) . . (+67). . Jwarner (talk | contribs)
 m   20:20  Myelodysplastic syndrome‎ (diff | hist) . . (+28). . Jwarner (talk | contribs)
 m   20:06  Waldenström macroglobulinemia‎ (diff | hist) . . (+12). . Jwarner (talk | contribs)
 m   20:06  Follicular lymphoma‎ (diff | hist) . . (+12). . Jwarner (talk | contribs)
 m   20:05  Marginal zone lymphoma‎ (diff | hist) . . (+12). . Jwarner (talk | contribs)
 m   20:03  Mesothelioma‎ (diff | hist) . . (+33). . Jwarner (talk | contribs)
 m   19:48  Breast cancer, HER2-positive‎ (diff | hist) . . (+354). . Jwarner (talk | contribs)
 m   19:48  Complex multipart regimens‎‎ (2 changes | history) . . (+44). . [Jwarner‎ (2×)]
 m    19:48 (cur | prev) . . (+22). . Jwarner (talk | contribs) (References)
 m    19:47 (cur | prev) . . (+22). . Jwarner (talk | contribs) (References)
 m   19:42  Prostate cancer - historical‎ (diff | hist) . . (+75). . Jwarner (talk | contribs) (Castration)
 m   19:39  Gastric cancer‎ (diff | hist) . . (+50). . Jwarner (talk | contribs)
 m   19:26  Peripheral T-cell lymphoma‎ (diff | hist) . . (+384). . Jwarner (talk | contribs)
     19:25 (Upload log) . . Jwarner (talk | contribs) uploaded File:NShah.png
 m   10:53  Small cell lung cancer - historical‎ (diff | hist) . . (+2). . Jwarner (talk | contribs)
 m   10:52  Small cell lung cancer‎ (diff | hist) . . (+10). . Jwarner (talk | contribs)
 m   10:50  Acute myeloid leukemia‎ (diff | hist) . . (+127). . Jwarner (talk | contribs)
N    04:23  User:Rachelchee‎ (diff | hist) . . (+168). . PeterYang (talk | contribs) (Created page with "Rachel Chee is a pharmacist with an interest in oncology drug informatics. She is a member of the OHDSI Oncology Workgroup with expertise in the area of oncology drugs.")
N    04:17  User:Nishishah‎ (diff | hist) . . (+179). . PeterYang (talk | contribs) (Created page with "Nishi Shah, MD is a hematology/oncology fellow at Montefiore Medical Center and Albert Einstein College of Medicine and is Page Editor for the Peripheral T-cell lymphoma p...")
     03:52  (User rights log). . [Dryang‎ (2×)]
      03:52 . . Dryang (talk | contribs) changed group membership for Rachelchee from (none) to editors and emailconfirmed ‎
      03:52 . . Dryang (talk | contribs) changed group membership for Nishishah from (none) to editors and emailconfirmed ‎

22 June 2019

     16:45 (User creation log) . . User account Aminrx (talk | contribs) was created ‎
 m   14:42  Ontology‎ (diff | hist) . . (+239). . Jwarner (talk | contribs) (References and acknowledgements)
 m   12:28  Gallbladder cancer‎ (diff | hist) . . (+385). . Jwarner (talk | contribs) (Adjuvant therapy)
 m   12:25  T-cell acute lymphoblastic leukemia‎ (diff | hist) . . (+125). . Jwarner (talk | contribs) (Guidelines)
 m   12:24  B-cell acute lymphoblastic leukemia, Ph-positive‎ (diff | hist) . . (+872). . Jwarner (talk | contribs)
 m   12:23  B-cell acute lymphoblastic leukemia‎ (diff | hist) . . (+125). . Jwarner (talk | contribs) (NCCN)
 m   12:07  Hereditary hemorrhagic telangiectasia‎ (diff | hist) . . (-5). . Jwarner (talk | contribs) (Tamoxifen acid monotherapy {{#subobject:b1894c|Regimen=1}})

21 June 2019

 m   18:38  Diffuse large B-cell lymphoma - historical‎ (diff | hist) . . (+14). . Jwarner (talk | contribs)
 m   18:36  Waldenström macroglobulinemia‎ (diff | hist) . . (-45). . Jwarner (talk | contribs)
 m   18:34  Follicular lymphoma - historical‎ (diff | hist) . . (-28). . Jwarner (talk | contribs)
 m   18:32  Small cell lung cancer - historical‎ (diff | hist) . . (-68). . Jwarner (talk | contribs)